Drugs targeting different metabolic pathways induced in tumors may be used in combination with one another to induce synthetic lethality in cancer cells, while preserving the survival of normally proliferating cells.
Karim Bensaad, PhD
Advertisement
Articles by Karim Bensaad, PhD
Advertisement
Latest Updated Articles
- Cancer Metabolism as a Therapeutic Target: Metabolic Synthetic Lethality
Published: May 15th 2013 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Alectinib Upholds OS Benefit in Advanced ALK+ NSCLC
2
Sevabertinib Monotherapy Elicits Durable Responses in HER2-Mutant NSCLC
3
Zongertinib Maintains Efficacy Benefit in First-line HER2-Mutated NSCLC
4
Episode 16: Anticipated ESMO 2025 Data That May Change GU Oncology
5
